The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis

✍ Scribed by G.F.L. Hofbauer; A. Marcollo-Pini; A. Corsenca; A.D. Kistler; L.E. French; R.P. Wüthrich; A.L. Serra

• Book ID: 108670145
• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 185 KB
• Volume: 159
• Category: Article
• ISSN: 0007-0963
• DOI: 10.1111/j.1365-2133.2008.08677.x